Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
incyte
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
avrobio
baricitinib
biotech
cancer
crispr
eli lilly
gene editing
glaxosmithkline
johnson & johnson
president trump
What
roundup
bio
ahead
ambien
american
annual
asco
attendees
attention
biopharma
biotech
black
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
companies
congress
congressional
continue
crispr
days
debut
diamond
diamond’s
drug
executives
expanding
feud
focus
group
home
indication
isn’t
key
kicks
Language
unset
Current search:
incyte
×
sanofi
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More